S-3-hydroxyphenyl (N-hydroxycarbamamido) (diphenyl) ethanethioate derivatives as potential inhibitors of 5 -Lipoxygenase (5-LOX)

Authors

  • Ariza-Rua, Danilo
  • Rebollo, Juan Alberto
  • Chavarro-Mesa, Edisson
  • Ballestas-Casallas, Yamil

DOI:

https://doi.org/10.18687/LACCEI2023.1.1.1222

Keywords:

5-Lipoxygenase, molecular docking, anti-inflammatory drugs

Abstract

We have designed and docked derivatives of a new anti-inflammatory compound into the crystal structure of the Lipoxygenase-5 (LOX-5) enzyme. We found that four derivatives have the same ability to inhibit the activity of the enzyme as the anti-inflammatory drug Zileuton. This information may help us develop new compounds to treat inflammation.

Downloads

Published

2023-07-27

Issue

Vol. 1 No. 8 (2023): LACCEI 2023

Section

Articles

Copyright

Copyright (c) 2023 LACCEI

View LACCEI official copyright policy

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

LACCEI retains copyright of all published articles under the terms of its copyright transfer agreement. As the copyright holder, LACCEI distributes the articles to the public under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

How to Cite

Ariza-Rua, Danilo, Rebollo, Juan Alberto, Chavarro-Mesa, Edisson, & Ballestas-Casallas, Yamil. (2023). S-3-hydroxyphenyl (N-hydroxycarbamamido) (diphenyl) ethanethioate derivatives as potential inhibitors of 5 -Lipoxygenase (5-LOX). LACCEI, 1(8). https://doi.org/10.18687/LACCEI2023.1.1.1222

Most read articles by the same author(s)